Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2021

Month: July

Request Number: A-2020-001895

Request Summary: Adverse Reaction Reports (AERs) for Mezavant. Report numbers: E2B_03321791, 919523, 924749, E2B_03284156, E2B_03286468, E2B_03292641, E2B_03302640. (ADRs) for Vyvanse. Report numbers: E2B_03300503, E2B_03287086, E2B_03284951. (ADR) for C1 Esterase Inhibitor (Human). Report number: E2B_03287283. (ADRs) for Immunoglobulin (human). Report numbers: E2B_03320951, E2B_03299907, E2B_03286704.

Disposition: Disclosed in part

Number of pages: 193

Date modified: